ArticleACS medicinal chemistry letters2021

Evaluation of 5-(Trifluoromethyl)-1,2,4-oxadiazole-Based Class IIa HDAC Inhibitors for Huntington's Disease.

Andrew J Stott et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.